Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Excessive hoarding in Parkinson's disease.

O'Sullivan SS, Djamshidian A, Evans AH, Loane CM, Lees AJ, Lawrence AD.

Mov Disord. 2010 Jun 15;25(8):1026-33. doi: 10.1002/mds.23016.

PMID:
20131391
2.

Impulsive choice and response in dopamine agonist-related impulse control behaviors.

Voon V, Reynolds B, Brezing C, Gallea C, Skaljic M, Ekanayake V, Fernandez H, Potenza MN, Dolan RJ, Hallett M.

Psychopharmacology (Berl). 2010 Jan;207(4):645-59. doi: 10.1007/s00213-009-1697-y. Epub 2009 Oct 20.

3.

Integration of social and utilitarian factors in decision making.

Averbeck BB, Duchaine B.

Emotion. 2009 Oct;9(5):599-608. doi: 10.1037/a0016509.

PMID:
19803582
4.

At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists.

Abler B, Hahlbrock R, Unrath A, Grön G, Kassubek J.

Brain. 2009 Sep;132(Pt 9):2396-402. doi: 10.1093/brain/awp170. Epub 2009 Jun 30.

PMID:
19567700
5.

Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients.

Bódi N, Kéri S, Nagy H, Moustafa A, Myers CE, Daw N, Dibó G, Takáts A, Bereczki D, Gluck MA.

Brain. 2009 Sep;132(Pt 9):2385-95. doi: 10.1093/brain/awp094. Epub 2009 May 4.

6.

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study.

Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, Rusjan P, Houle S, Strafella AP.

Brain. 2009 May;132(Pt 5):1376-85. doi: 10.1093/brain/awp054. Epub 2009 Apr 3.

7.

Personality, addiction, dopamine: insights from Parkinson's disease.

Dagher A, Robbins TW.

Neuron. 2009 Feb 26;61(4):502-10. doi: 10.1016/j.neuron.2009.01.031. Review.

8.

Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration.

Cools R, Frank MJ, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M.

J Neurosci. 2009 Feb 4;29(5):1538-43. doi: 10.1523/JNEUROSCI.4467-08.2009.

9.

Role of dopamine in the motivational and cognitive control of behavior.

Cools R.

Neuroscientist. 2008 Aug;14(4):381-95. doi: 10.1177/1073858408317009. Review.

PMID:
18660464
10.

Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores.

Mamikonyan E, Moberg PJ, Siderowf A, Duda JE, Have TT, Hurtig HI, Stern MB, Weintraub D.

Parkinsonism Relat Disord. 2009 Mar;15(3):226-31. doi: 10.1016/j.parkreldis.2008.05.006. Epub 2008 Jul 2.

11.

The neurobiology and genetics of impulse control disorders: relationships to drug addictions.

Brewer JA, Potenza MN.

Biochem Pharmacol. 2008 Jan 1;75(1):63-75. Epub 2007 Jul 3. Review.

12.
13.

Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.

Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M.

Arch Neurol. 2007 Feb;64(2):212-6.

PMID:
17296836
14.

Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder.

Frank MJ, Santamaria A, O'Reilly RC, Willcutt E.

Neuropsychopharmacology. 2007 Jul;32(7):1583-99. Epub 2006 Dec 13.

15.

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.

Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J.

Neurology. 2006 Oct 10;67(7):1254-7. Epub 2006 Sep 6.

PMID:
16957130
16.

Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans.

Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD.

Nature. 2006 Aug 31;442(7106):1042-5. Epub 2006 Aug 23.

17.

Impulse control disorders in Parkinson's disease.

Weintraub D, Potenza MN.

Curr Neurol Neurosci Rep. 2006 Jul;6(4):302-6. Review.

PMID:
16822350
18.

Prospective prevalence of pathologic gambling and medication association in Parkinson disease.

Voon V, Hassan K, Zurowski M, Duff-Canning S, de Souza M, Fox S, Lang AE, Miyasaki J.

Neurology. 2006 Jun 13;66(11):1750-2.

PMID:
16769956
19.

Reversal learning in Parkinson's disease depends on medication status and outcome valence.

Cools R, Altamirano L, D'Esposito M.

Neuropsychologia. 2006;44(10):1663-73. Epub 2006 May 26.

PMID:
16730032
20.

Compulsive drug use linked to sensitized ventral striatal dopamine transmission.

Evans AH, Pavese N, Lawrence AD, Tai YF, Appel S, Doder M, Brooks DJ, Lees AJ, Piccini P.

Ann Neurol. 2006 May;59(5):852-8.

PMID:
16557571

Supplemental Content

Support Center